Le Pendu et al. [53], in a review of the association between ABO and COVID-19, concluded that the O group provided some protection in comparison with non-O groups, and this could be mediated either by natural anti-A and anti-B antibodies or by a lower efficiency of furin cleavage in the O group [54,55]. The gene discussed is ABO; the disease is COVID-19.